Qualitative investigation of patients' experience of a glaucoma virtual clinic in a specialist ophthalmic hospital in London, UK by Kotecha, A et al.
Qualitative investigation of patients’
experience of a glaucoma virtual clinic
in a specialist ophthalmic hospital in
London, UK
Aachal Kotecha, Karen Bonstein, Richard Cable, Jocelyn Cammack, Jane Clipston,
Paul Foster
To cite: Kotecha A,
Bonstein K, Cable R, et al.
Qualitative investigation of
patients’ experience of a
glaucoma virtual clinic in a
specialist ophthalmic hospital
in London, UK. BMJ Open
2015;5:e009463.
doi:10.1136/bmjopen-2015-
009463
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-009463).
Received 20 July 2015
Revised 28 September 2015
Accepted 17 November 2015
NIHR Biomedical Research
Centre for Ophthalmology at
Moorfields Eye Hospital NHS
Foundation Trust and UCL
Institute of Ophthalmology,
London, UK
Correspondence to
Aachal Kotecha;
aachal.kotecha@ucl.ac.uk
ABSTRACT
Objectives: To explore how patients felt about
delivery of care in a novel technician-delivered virtual
clinic compared with delivery of care in a doctor-
delivered model.
Design: A qualitative investigation using one-to-one
interviews before and after patients’ appointments at
either the standard outpatient glaucoma clinic or the
new technician-delivered virtual glaucoma clinic
(Glaucoma Screening and Stable Monitoring Service,
GSMS).
Setting: A glaucoma clinic based in a tertiary
ophthalmic specialist hospital in London.
Participants: 43 patients (38 Caucasian, 5 African/
Afro-Caribbean) were interviewed prior to their
glaucoma appointment; 38 patients were interviewed
between 4 and 6 weeks after their appointment.
Consecutive patients were identified from patient
reception lists and telephoned prior to their
appointment inviting them to participate.
Results: Trust in the patient–provider relationship
emerged as a key theme in patients’ acceptance of not
being seen in a traditional doctor-delivered service.
Patients who were well informed regarding their
glaucoma status and low risk of progression to sight
loss were more accepting of the GSMS. Patients valued
the reassurance received through effective
communication with their healthcare practitioner at the
time of their appointment.
Conclusions: This study suggests that patients are
accepting of moving to a model of service delivery
whereby the doctor is removed from the consultation
as long as they are informed about the status of their
condition and reassured by the interaction with staff
they meet. This study highlights the importance of
patient engagement when introducing new models of
service delivery.
BACKGROUND
Glaucoma is the leading cause of irreversible
blindness in the developed world, and
increases in prevalence with advancing age.1
It is a chronic condition which requires life-
long monitoring once diagnosed. The
number of new glaucoma suspect referrals
into the hospital eye service (HES) is increas-
ing, partly due to the advances in diagnostic
technologies used by primary eye care provi-
ders.2 This, combined with the increasingly
ageing population, has led to some hospital
eye departments to predict capacity problems
in meeting demand for ophthalmology out-
patient services.3–5
An approach to meeting increasing
demands for services is to remove the
face-to-face doctor consultation and imple-
ment a ‘virtual clinic’ within the secondary
care setting, whereby nurses or ophthalmic
technicians collect data from the patient for
a consultant ophthalmologist to review at a
later time. Glaucoma lends itself to such a
model of care as the disease is usually moni-
tored using digital imaging and functional
testing devices6 that may be administered by
Strengths and limitations of this study
▪ This is the first qualitative interview-based study
obtaining views from patients regarding how
their glaucoma care is delivered, and how they
feel about the move to non-doctor-delivered
services.
▪ Interviews were performed on a one-to-one basis
before and 1 month after patients’ appointments.
▪ All patients participating in the study had English
as their first language and were predominantly of
Caucasian ethnicity; thus, they may not reflect
the views of the wider glaucoma patient
population.
▪ The study was performed at a single tertiary
referral ophthalmic centre in London; thus, geo-
graphical differences in patient opinion still need
to be explored.
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trained technical staff. There are a number of National
Health Services (NHS) departments around the UK
(personal communication: Simon Longstaff, Consultant
Ophthalmologist Royal Hallamshire Hospital, Shefﬁeld,
January 2014; Jane Kingett, Advanced Ophthalmic
Practitioner—Glaucoma Service Lead, West of England
Eye Unit, February 2014),7–9 and independent sector
providers10 who use this model.
The key factor in the ‘virtual clinic’ is that it removes
the ophthalmologist from the face-to-face patient con-
sultation. The rationale for their implementation within
hospitals is that they both improve the patient journey
and improve clinic capacity (personal communication,
Simon Longstaff, Consultant, Royal Hallamshire
Hospital, Shefﬁeld, January 2014).
The Glaucoma Service at Moorﬁelds Eye Hospital,
London, opened a virtual clinic (the Glaucoma
Screening and Stable Monitoring Service, GSMS) in
March 2014. The purpose of this qualitative interview-
based study was to explore how patients felt about their
care delivery, and their impressions on moving away
from a doctor-delivered care model where they had
experience of both. Patients attending both the trad-
itional consultant-delivered outpatient clinics as well as
those attending the GSMS were interviewed. For some
patients, it was their ﬁrst visit to the hospital for assess-
ment (whether at GSMS or in a consultant-delivered
clinic) following a referral by an optometrist or general
practitioner.
METHODS
The GSMS was suitable for low-to-moderate risk,
new glaucoma suspect patients, or patients with
low-to-moderate stage stable existing glaucoma at low
risk of progression, as deemed by their consultant. For
new patients, ‘low-to-moderate’ risk was deﬁned as
having up to two of the following risk factors for devel-
oping glaucoma: raised intraocular pressure, suspicious
looking optic nerves, suspicious visual ﬁelds, positive
family history. For existing patients, ‘low’ and ‘moderate’
disease stages were deﬁned using a modiﬁed version of
the Canadian Glaucoma Society disease staging guide-
lines.11 The GSMS opened in March 2014. Figure 1
shows a ﬂow diagram describing the new and existing
patient journeys through both the GSMS and the glau-
coma outpatient clinic.
Semistructured interviews were conducted in the
Outpatient Department at Moorﬁelds Eye Hospital NHS
Foundation Trust, London, UK, between August and
November 2014. Four patient groups were identiﬁed:
1. Those attending a new patient appointment in the
GSMS,
2. Those attending a new patient appointment in the
consultant-delivered glaucoma outpatient service,
3. Those attending a follow-up appointment in the
GSMS, and
4. Those attending a follow-up appointment in the
consultant-delivered glaucoma outpatient service.
Figure 1 Flow charts illustrating (A) new patient and (B) stable patient journey. GP, general practitioner; GSMS, Glaucoma
Screening and Stable Monitoring Service; EPR, electronic patient record.
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A sample size of 10–12 patients from each group was
proposed as being likely to represent a range of views
while also being practical for researchers to analyse.12
The sample size ﬁts well with other qualitative research
projects into glaucoma patient perceptions.13–15
Patients attending the consultant-delivered glaucoma
outpatient clinics and the technician-delivered GSMS
were invited to participate via a telephone call made
between 1 and 5 days prior to their scheduled
appointment.
The patient selection process was as follows: reception
lists for both types of clinic were printed off in advance.
For those attending the GSMS, consecutive patients were
telephoned and invited to participate. For those attend-
ing a consultant-delivered outpatient appointment, con-
secutive scheduled patients had their hospital records
examined by a clinician (AK) to establish that they were
of a similar disease stage/risk as those attending the
GSMS. Once identiﬁed, patients were telephoned and
invited to participate. All invitations were made by the
same clinician (AK). Patients were advised that the
purpose of the interviews was for a service evaluation
project and that they would be interviewed immediately
before their clinic appointment and interviewed again
approximately 1 month later via telephone. All patients
attending the GSMS were new to the clinic—that is, any
returning patients had previously attended the regular
consultant-delivered outpatient clinic and had no previ-
ous experience of the new GSMS clinic.
The project conformed to the tenets of the
Declaration of Helsinki and informed consent was taken
prior to the start of each interview. Interviews were con-
ducted by one of four people (KB, RC, JCl, JCa) using a
predetermined topic guide (ﬁgure 2). The topic guide
was developed based on some of the common free-text
responses to an in-house patient satisfaction feedback
form given to patients attending the GSMS in the pre-
ceding months, as well as the service managers’ interest
into how the service was being perceived.
Preappointment interviews took place in a quiet waiting
area in the hospital that was out of the earshot of other
patients and staff. Patients were advised that the interviewer
would take verbatim notes regarding their statements and
that all responses would be anonymised. Once notes had
been taken, the interviewer would read back their notes to
the patient to conﬁrm that they had captured the patient’s
responses to questions asked. Postappointment interviews
were conducted via telephone at a time convenient to the
patient. A half hour slot was given for each interview,
although interviews were terminated when the end of the
topic guide had been reached and/or patients had
nothing further to add. The team involved in conducting
the interviews was not part of the patients’ clinical care
team and did not work in the hospital’s glaucoma depart-
ment. All researchers were part of the University College
London Biomedical Research Centre (Ophthalmology)
Public and Patient Involvement team and were involved
and experienced in qualitative research exercises.
Demographic data and medical information pertain-
ing to the patient’s diagnosis data was also collected.
The study protocol was developed and is reported
according to the Consolidated Criteria for Reporting
Qualitative Research (COREQ).16
Data analysis
All notes were transcribed to an Excel spreadsheet and
analysed by four of the authors (RC, JCl, JCa, AK) using
a thematic framework approach.17 Transcripts were ini-
tially descriptively coded (open-coded) by each member
of the analysis team individually, who then met to
perform analytical coding during group discussions until
consensus agreement was reached. Themes were identi-
ﬁed using a thematic analysis approach.17
RESULTS
The demographics of the patient groups are displayed
in table 1.
Figure 3 illustrates the themes and subthemes that
emerged from the analysis. Six main subthemes were
identiﬁed and these will be explored in greater detail,
using patient quotes as examples. Patients have been
identiﬁed as to whether they were new or existing
follow-up (FU) patients, whether they attended the
virtual (GSMS) or consultant-led clinic, and by their
gender (M=male, F=female).
Figure 2 Interview topic guide.
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Trust
The theme that was at the core of most patients’ percep-
tions regarding moving from a traditional doctor-led
service to a ‘virtual clinic’ was their trust and conﬁdence
in the systems and processes of their care pathway.
Existing patients who trusted their clinical care team
were more open to being moved into the GSMS:
They know when I should see a doctor. I feel if they
think I should see a doctor, they will tell me.—FU GSMS
5, F
Not really concerned[if I do not see a doctor today] as
my condition is not currently serious. If I felt condition
was deteriorating[I] would be more aware of who I was
seeing and would want to see someone correspondingly
senior. I wouldn’t be particularly concerned if I didn’t
see a doctor every time.—FU Consultant 2, F
Patients who were less informed regarding the nature
and status of their condition or the care processes were
less trusting of the new clinic. Similarly, some patients
expressed mistrust about the agenda behind the change.
As themes began to emerge from the data it became
evident that trust was the key factor linking all other
themes and subthemes. These will be discussed in
further detail below.
Prior information
Prior information played a key role in patients’ percep-
tions of their eye care within the HES. This was further
split into subthemes which pertained to the administra-
tive processes within the pathway and the clinical infor-
mation they received regarding their condition. This
theme encompasses communication, in many forms, of
information such as: why they were attending the
service, why they had been moved to the GSMS, the sta-
bility of their clinical condition in terms of their risk of
signiﬁcant visual loss and the need to see the doctor.
As indicated in ﬁgure 1, all patients transferred to the
GSMS should have a patient information leaﬂet
Table 1 Demographics of patients interviewed
GSMS ‘new
patient’ (n=11)
Consultant clinic
‘new patient’
(n=10)
GSMS ‘follow-up
patient’ (n=11)
Consultant clinic
‘follow-up patient’
(n=11)
Average age (years) 63 63 66 72
Age range (years) 40–80 39–84 43–78 57–83
Male:female ratio 6:5 6:4 6:5 4:7
Ethnicity 10 Caucasian
1 African/
Afro-Caribbean
10 Caucasian 9 Caucasian
2 African/
Afro-Caribbean
9 Caucasian
2 African/
Afro-Caribbean
Number of patients where no
postappointment interview was
available
1 2 1 1
In total, there were five patients for whom postappointment interviews were not available, due to an inability to contact the patient following
their appointment. GSMS, Glaucoma Screening and Stable Monitoring Service.
Figure 3 Themes and
subthemes identified during the
coding process. HCP, healthcare
practitioner.
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describing the clinic. In addition, patients with existing
glaucoma who had been transferred to the GSMS at
their previous appointment should have had the move
discussed with them at their previous visit.
Patients who were well informed tended to be more
accepting of the service they received:
I received a letter explaining that I would have tests done
by a technician and that the results would come to my
GP in about 2–3 weeks. The technician in the clinic has
also explained this when she greeted me…I am happy
with the information…[I] just expect to see the techni-
cian.—New GSMS 1, F
My optician noticed pressure behind the eye and gave
me a letter. I then took the letter to my doctor. I was
[sent] a booklet containing directions to the hospital/
clinic and information on what to bring and a letter con-
ﬁrming who my appointment is with. All of the informa-
tion was very useful. I expect to see a doctor today but
[the letter said] it could be someone else.—New
Consultant 2, M
However, it was clear that some patients did not get as
much information or received confusing information:
There was nothing in the letter about where to go. I
asked at the general reception when I arrived and they
sent me to clinic 2. When I got there, they didn’t think I
should be there and sent me to clinic 3. They[clinic 2]
didn’t think I should be there so I was sent back to clinic
2 and then I was sent over here…I’m not anxious about
my appointment so it hasn’t been a problem for me but
if I had been worried about it, I think it would have been
unnerving…—New Consultant 3, M
[I am] a little disappointed[about not seeing a doctor
today] as I didn’t receive a letter explaining the[virtual]
clinic. On arrival, the technician-service was explained
well but there is still some disappointment.—New GSMS
6, M
In cases where patients had not received prior infor-
mation regarding the nature of the GSMS, screening
‘failure’ added to their anxiety:
I am not happy not seeing a doctor[at the virtual clinic
visit];[I] have a follow-up appointment in November
which is too long to wait!—New GSMS 6, M
This is despite the fact that the reviewing consultant
would have chosen an appropriate follow-up interval
based on the results of the screening tests.
Prior clinical information pertaining to the reasons
for their referral into the clinic also played a signiﬁcant
part in patient experiences. The previous experiences of
ophthalmic care, and communication from the care pro-
vider, coloured their expectations of the service they
would be receiving:
The optician had reported seeing nerve damage and I
have a family history of glaucoma.[I am] not concerned
[if I do not see a doctor] as long as tests are thorough
and promptly evaluated.[I] want to be sure that it is not
left too long if treatment is needed.[I] would like a
doctor to explain what the optician said as optician made
referral but just talked about seeing ‘ nerve damage’, and
[I] have had no explanation of possible course of condi-
tion or cause.—New GSMS 4, F
In cases where ambiguous clinical information regard-
ing the reasons for referral were given, the lack of doctor
contact and screening failure also led to greater anxiety:
[The letter had] no information, no outcome, no explan-
ation. Just a letter saying I ‘would beneﬁt from a review
in one of our consultant led clinics’. The appointment
for this is in 3 months! I am worried in case I need treat-
ment and am having to wait this long for it to start. I
have a family history of glaucoma so am anxious about
this and would like to know what they found / what the
results of my tests were.—New GSMS 4, F
Existing patients booked into the GSMS are stable
patients at low risk of progressing to signiﬁcant visual loss.
It might be expected that this would in itself allay patients’
concerns about the stability of their condition; however,
there were some patients who expressed an anxiety at not
seeing a doctor on the day of their GSMS visit:
Would be concerned[if I did not see a doctor] because
of the nature of why I’m here.[It is] comforting to see
the top person especially for pressure check.—FU
Consultant 3, F
I deﬁnitely want to see a doctor. That is why you come to
a hospital, you come because you have a serious condi-
tion.—FU Consultant 5, F.
Engagement
Another major theme that emerged from the data con-
cerned the level of engagement patients had with their
condition and their care. This theme linked closely with
‘prior information’ since those who were more engaged
tended actively to seek out more information, both inde-
pendently and through the hospital. Some patients
trusted that their care team had the professional expert-
ise to decide what was in their best interests, and as such
did not wish or feel the need to question the care deci-
sions made. Others appeared not to be informed as to
why they were attending for their follow-up appointment
or the nature of their condition, but were happy to ‘take
a back seat’ in the process.
All new to me so am just doing as I’m told and have no
expectations. Happy to leave it to the staff here to decide
who I need to see.—New Consultant 1, F
Other patients valued the consultation and wished to
be jointly engaged in discussions of the care decisions
made:
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[I] didn’t have much explanation of the results.[I] would
have preferred to have more information.[I] would like
more information of test results at the next appointment.
—FU Consultant 6, F
I saw the consultant and felt that I was in the best hands
possible. We both came to a decision on my diagnosis
and the treatment.—New Consultant 3, M.
Patient/healthcare practitioner interaction
This theme revolved around the patient/practitioner
relationship and how patients valued the rapport that
existed within the traditional doctor/patient consult-
ation. Patients viewed the consultation aspect of the visit
as a chance to receive ‘reassurance’ regarding their con-
dition and progress. Those who did not have time to
talk to the doctor, or who were unable to build a
rapport with the staff they saw at their appointment,
were not satisﬁed with the care they received:
[I had] only a very short time with the consultant. I was
disappointed because he hadn’t read the notes: he asked
about the drops (I am not on drops), and didn’t tell me
what the pressure was—I had to ask. He said I would
have to see just the nurses next time…but I am worried
about that.—FU Consultant 8, F
Those who were moved to the virtual clinic were
unsure of the roles and responsibilities of the techni-
cian, which led to a degree of uncertainty as to what
they could or could not ask about their condition:
I did feel safe. My pressure was a bit higher but I wasn’t
sure about quizzing the technician. He was good though
and looked back through the notes to reassure me this had
happened before. He also explained that I would be called
back if the doctor looking at the results was worried…it was
ok…Maybe the technicians could invite the patient to ask
questions. Perhaps a bit more interaction with the techni-
cians[could be an improvement].—FU GSMS 2, F
I don’t know what a ‘technician’ is or does, in terms of
[their] qualiﬁcations[and their] authority. I would have
liked information beforehand on what a technician is,
because sometimes it can be a derogatory term—‘only a
technician’.—FU GSMS 1, M
The experience in the virtual clinic was very staff
dependent, with some technicians clearly outperforming
others in terms of the service they gave:
The staff were very, very professional…They explained
everything and told me I wouldn’t see a consultant…The
way they were working made me feel safe.—FU GSMS 5, F
There was an explanation of a kind but perhaps it is difﬁ-
cult to explain a technical procedure to a non-technical
person.[My] only reservation was that there was a slight
language barrier as the English was not[the technician’s]
ﬁrst language, so[the interaction was] not quite idiom-
atic.—New GSMS 11, M.
Clinical assessment process
There were views on the clinical assessment process that
covered aspects of waiting times and efﬁciency, as well as
the terminology used and the move towards more
technological advances in the assessment process.
Overall, patients expected long waiting and journey
times:
Usually takes a long time, there is a long wait at the ﬁelds
test. Then I see a doctor, it usually takes a long time.
Sometimes I have to wait for an hour to see the doctor
after the ﬁelds test.[This time] there was too long a wait:
I was there for 2 hours. And then I only had a very short
time with the consultant.—FU Consultant 8, F
I had to wait for quite some time[before I was seen]. I
found it hard to ﬁnd my way through the hospital. I had
several tests and had to wait a long time to be seen ini-
tially. My visit lasted over 3 hours…The waiting times are
too long…It is particularly hard if you are visiting alone.
—New Consultant 1, F
Patients moved to the GSMS made positive comments
on the organisation of the clinic:
I was happy with more tests being done at this appoint-
ment compared with previous appointments with the
doctor.[I] felt like my eyes were tested thoroughly as a
result of this.—FU GSMS 4, M
[There was] nothing that didn’t work well…I was seen on
time…I was told what each[test] was for before they did
it.[It was] all laid out like an assembly line, straight from
one[machine] to the other. Very efﬁcient…It was very
thorough, I didn’t realise how thorough it would be, it
was very reassuring…Good to know there is a part of the
NHS which can look after you like that.—New GSMS 3, M
However, some patients expressed an anxiety as to
whether their performance would affect test results,
which in turn might affect the clinical decisions made
by the care team:
I felt the visual ﬁelds test wasn’t accurate. They ran too
many tests too quickly and didn’t give my eyes enough
time to adjust. The tests weren’t explained thoroughly
but I was told there was no major worry.—FU Consultant
11, M
When I had the peripheral vision test, I wasn’t asked a
question about my general wellbeing on the day. General
wellbeing questions are needed before being tested[as
they may affect results].—New Consultant 3, M
Some patients also commented on the modernisation
of the hospital, in particular the use of more
technology:
[There] was a bit of a concern about not seeing a consult-
ant. …I have reservations, there is the comfort factor,
there is more chance of an error like this…I am
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concerned that the test results won’t reach the consultant
and that now more records could be lost.—FU GSMS 3, F.
Reason for change
Patients were diverse in their opinions on the changes to
service delivery, with some understanding the need for
improvement and appreciating the efﬁciency of the
virtual clinic, with others concerned about the agenda
behind the change:
[I am] not happy with[commercial coffee shop], far too
expensive…Hospitals shouldn’t be depending on com-
mercial money, they should get more government
funding. I feel it is important to maintain high standards
of qualiﬁed expertise and care in the NHS and this may
be under threat from new initiatives.—FU Consultant 5, F
I would like to know why the change has been made…is
it to save money?—FU GSMS 3, F
Technology coming along can be more efﬁcient than
‘human frailties’…I am all in favour of improvements
and efﬁciency, I move with the times.[But] I would
prefer to see a doctor…I am a doctor myself[and have]
worked in the health service for 40 years. I don’t like
taking the doctor out of the appointment process.—FU
GSMS 6, M.
DISCUSSION
The ﬁndings of this qualitative interview-based study
suggest that patient acceptance of new pathways for
their glaucoma care centred around trust, which was pri-
marily built through communication between the care
provider and the patient. That said, it was evident that
some patients implicitly trusted the care teams’ decisions
based on the reputation of the hospital and the per-
ceived professional expertise that they received.
New patients attending the service had no preconcep-
tions regarding the care pathway, and so their percep-
tions were very much coloured by the prior information
received, either from the hospital or their referring prac-
titioner. Some new patients seen in the virtual clinic
expressed an anxiety at not seeing a doctor on the day
as they had the perception that their condition was
serious, based on the information received by their
referring practitioner. Some patients with existing glau-
coma felt similar levels of anxiety at removing the doctor
from the consultation and moving to a virtual clinic
pathway, despite the service only being suitable for
stable, low-risk patients.
Glaucoma comprises a wide spectrum of disease
ranging from very early disease with low risk of progres-
sion to signiﬁcant sight loss, to those at a more advanced
stage with a high risk of progressing to advanced visual
loss. It has been shown that those presenting to the UK
HES with early disease are at a low risk of progressing to
blindness.18 Only those patients judged to be at the low
risk end of the spectrum would be suitable for the
virtual service. Our study revealed that some patients
were better informed than others regarding their risk of
progression to blindness, and it may be that this lack of
knowledge about disease status and risk is due to failings
in doctor/patient communication. In their qualitative
study evaluating patient perceptions of the visual ﬁeld
test, Glen et al15 also discuss how effective doctor/
patient communication could inﬂuence patient
responses to follow-up care. Indeed, in our study, those
patients who were well informed about their own disease
status were very comfortable with the move away from
the face-to-face consultation, particularly if it resulted in
greater efﬁciency and less waiting/journey times at their
appointment.
It was clear that some patients did not receive sufﬁ-
cient prior information regarding the change to their
care pathway, which led to anxiety on arrival at the
virtual clinic. It is unclear as to whether patients did not
receive or did not read the information sent to them;
however, for some there were failings in the administra-
tive processes. Informed patients knew what to expect
and were more relaxed as a result. Those who did not
have information were much more concerned about the
care they would receive and whether it would be to the
same standard as that of previous consultant-led visits.
Since completing this study, we have developed a patient
education video, available on the hospital website, to
which patients booked into the service are directed, as
well as reiterating to all administrative staff the import-
ance of providing patient information leaﬂets. We have
also emphasised to clinicians working in outpatient
clinics the importance of face-to-face communication
during the doctor/patient consultation regarding a pro-
posed move to the stable clinic. It is likely that this latter
method of communicating change will be the most
effective at instilling patient trust and alleviating any
patient anxiety with respect to moving from the trad-
itional doctor-led delivery of care.
Reports by the Picker Institute have shown that
patients wish to be involved in decisions about their
care,19 and it has been shown that patients with chronic
disease who are more informed about their condition
and care needs have better health outcomes.20 For some
patients, the reputation of the hospital and the previous
experience of care within the hospital both contributed
to a sense of trust that the decisions made would be in
the patient’s best interest. For others, the perceived pro-
fessional expertise of the care providers was enough for
them to trust that they would be in a better position to
decide what was best for the patient. However, patients
who wished to be actively involved in care decisions and
who felt that they were not given the opportunity to
discuss things with the doctor were less trusting of the
care they received at their appointment. Patients are all
unique and while there are some who value in-depth dis-
cussions regarding how to best manage their condition,
for some, too much information can be overwhelming.21
While the majority of patients had very positive views
about the GSMS, some patients missed aspects of the
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doctor/patient consultation, with some being unsure of
the boundaries of the technician/patient relationship.
Rapport between the doctor and patient positively
impacts on patient satisfaction and patient outcomes.22 23
In this study, patients who were able to build up a
rapport with their healthcare professional felt reassured
and, consequently, satisﬁed with the care they received,
even though they did not receive information on their
disease status at their appointment. It is important to
remember that technicians delivering the GSMS are not
there to replace the doctor, and thus cannot comment
on the stability or otherwise of the patient’s condition.
However, those technicians who were able to effectively
communicate with the patient, in terms of what was
expected of them and what they should expect to
happen, who showed empathy with the patient, as well
as showing skill and competence with testing, inspired
conﬁdence and trust which contributed to a positive
patient experience. Thus, while the technicians will not
have the same relationship with the patient as the
doctor has had, the way they interact with the patient
can still provide the reassurance that the patient needs
from the appointment.
As with others’ ﬁndings,15 some patients made com-
ments with respect to the visual ﬁeld (VF) test and its
‘accuracy’ at detecting change. The variability and valid-
ity of the VF test and the inﬂuence of patient perform-
ance is widely known among glaucoma specialists24–26;
thus, results are always interpreted with caution.
However, this needs to be communicated to the patient,
so that they are reassured that clinicians are fully aware
of the impact of patient performance on test results and
how this is taken into account particularly when manage-
ment decisions are made remotely.
Another aspect that raised concern for some patients
was what was seen as an over-reliance on technology
which was associated with a greater chance of ‘lost data’.
Previous studies have suggested that older persons view
technology in healthcare with more suspicion, in part
due to their lack of familiarity with technology.27 This
suggests that there needs to be better communication
regarding how technology can make healthcare provi-
sion more efﬁcient, particularly when moving patients to
virtual services, in order to increase patient acceptance
of these models of service delivery.
The agenda behind the change in service delivery was
of some concern to a small number of patients. Rather
than being seen as a way to deliver services more efﬁ-
ciently, there were concerns that it was a cost-cutting
exercise and would result in reducing the quality of care
within the NHS. One patient in particular was very
defensive about the NHS and viewed any proposed
changes with great suspicion. This view may be in part
due to the political climate at the time the study was
conducted: the study was performed in a UK election
year, and thus there was much media coverage regarding
the future of the NHS under different government
administrations. However, it also reﬂects a deeper aspect
of how change, as well as the need for change, in service
delivery is communicated to patients.
Limitations to the study include the predominantly
Caucasian sample which was drawn from patients attend-
ing a specialist tertiary referral centre; thus, it is not
clear how well the ﬁndings may translate to other
departments. Furthermore, as postappointment inter-
views took place approximately 1 month following
attendance, there is a possibility that some aspects of the
appointment were not recalled and thus not captured by
the researchers. Further work is required to assess the
acceptability of new models of service delivery in differ-
ent patient populations.
In conclusion, this study suggests that patients are, on
the whole, accepting of moving to a model of service
delivery whereby the doctor is removed from the con-
sultation as long as they are informed about the status of
their condition and their risk of progression to severe
sight loss, and they are reassured by the method of data
collection and the interaction with personnel they see at
their appointment. Nonetheless, this study highlights
the importance of good communication as a way of
building trust between the provider and patient, so that
they perceive full transparency in how changes will
impact on their care without compromise to quality.
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